58
lcfter
Letter
Med J Indones
Are
sample
taker
and
obscurring
inflamma-tion i.mportant
in
getting an
adequatc
spe-cimen
?To the
editor
Adequacy
of
a
specimen has
been mentioned as
aprerequisite
for
agood diagnostic
reliability of
acer-vical
smear. Bethesdareporting
system hasmentioned
the
terrn
adequacy specimenin its terminology.t
This
study
aimsto
evaluate theimportance
of
sample takerand obscurring inflammation
as
the factors that
in-fluenced
the adequacyof
a smear.This study
washeld
at thecytology
laboratory,Depart-ment
of
Histology, Faculty lvfedicine, University of
Indonesia
from
May
1998until
December
1998.This
is
a
restrospective study.
Bethesdareporting
systemfor cytology
has been usedin this study.r
Adequacyof
specimen was determined
by looking
at
the presenceof
endocervical materiats
andthe defined
boundariesof targeting ceiis.
The X2 test was used as thestatistical
method.
Sample
ta-kerwas one
of
the most important
deter-minant
factor in
this study (P < 0.01, table
1).Table
1. Sample taker and the presence of endocervical materialSample taker The Presence of endocervical material
Endos
+
Endos-Table 2. The Presence of
a spesimen
inflammation and the adequacy of
X2
=6.81,P<0.01
Endos
= endocervical material ObGyn
= ObstetU and gynaecologyGP
= general practitionerObscurring inflammation was also
adominant
factor
that
might
influence
the
specimen
(P
<
0.01,Table
2).Prescnce of infl ammation Specimen adequate to be read
Adequate
Not adequateInilammation present Infl ammation not present
153
190
X2=53,P<0.01
Many
patients have been alarmed by media reportsthat
the Pap smear's false
negative
ratefor
thedetection
of
cervical
canceris
ashigh
as40 to 50
pcrcent.2
Sincefew
medical
personels understand that the Pap isnot
adiagnostic
test butonly
a screening test, manyof
themmade
aplan for
therapy
just
basedon its
result.
Ap-proximately
two third
of
the female population
in
Indonesia
has never been screenedfor
cervical
cancer,unless
accessto
dedicated
medical personel
is
im-prcved. The
screening
test
will
never
be
used
to
its
actual
potential.
Any
specimen designated
as
"unsatisfactory
for
evaluation" is
certainly
unreliable
for
thedeteciion
of
cervical epithelial
abnormalities and need
to
berepeated. "Satisfactory
for
evaluation
but
limited
by...,"
indicates
that the
specimen
provides
useful
information, however interpretation may
be
com-promised. The most
debatedtopic
in
this
category
isthe importance
of
anegative smear that
lacks
anen-docervical
component,r
because squamousprecursor
lesions most commonly arise
in
the
transformation
zone, so
it
is possibleto
arguethat
without
anevahra-tion
of
,this
region, a lesion could be potentially
bemissed."''''
The
absencecf
the endocervical
com-ponent
that accountfor
false negative
smearsis
due tosampling
"r.or.7-10 R.ecent studies have shown that the
use
of
anendocervical
brush can increase theyield of
endocervical cells
by sevenfold,ll
and
it
can also
beused
during pr"gnun"y.l2
Th"
ability
ro sample
ade-quately
correlates
with
the number
of
smears
takenunnuuly.'3
If
we
areinvestigating
forward
about the
unsatisfac-tory
smear,we
might find
that
the presenceof
exces-58
3
Total 343 6t
Ob Gyn Specialist GP/midwives
221 162
6
l5
Total 383 21
VoI9, No 1, January'March2000
sive
blood
and also predominance
of
leucocytes
mayinterf'ere
with
the
changesof
cells that we
have
ob-served.14The
terms
inflammatory atypia were
over-usedto refer to anything
irom
benign
reactive changesto preinvasive
cellular
changes,'
and presenceof
cer-vico-vagiual
infections
can lead to theinterpretation
of
a
highei
cytological
grading.ls
Many
vromen
with
invasive
cancer,
histoncally actually
have had
nega-tive
result
from
unsatisfactory
smears on."nie*.'4"
In
conclusion,
sample taker andobscurring
inflamma-tion
arevery
important factors
in getting
an adequatespecimen.
M.H. Roy
Sianturi
Department
of Histology,
Faculty of
Medicine'
University of
Indonesia,
JakartaREFERBNCES
1. National Cancer Institute Workshop. The revised Bethesda system
for
reporting cervicaVvaginal cytologic diagnoses: Report of the 1991 Bethesda Workshop. Acta Cytol 1992; 36:273-6.2. Koss LG. The Papanicolaou test for cervical cancer detec-tion: a triumph and a tragedy. JAMA 1989; 261:737-c3' 3. Isaacson C, Kurman RJ. The Bethesda system: a new
cias-sification
for
managing Pap smears' Contemp Obstet Gynecol 1995; 4C:67 -1 4.4. Vooijs PG, Eiras A, van der Graaf Y, Veling S. Relationship between the diagnosis
of
epithelial abnormalities and the composition of cervical smears. Acta Cytol 1985; 29:323 'Letter
595. Mitchell H, Medley G. Longitudinal study of women with negative cervical smears according to endocervical status: Victorian Cytology Servica, Melbourne, Australia. Lancet
l99l:337:265.
6. Kivlahan C, Ingram E. Papanicolaou smears without en-docervical cells:
Are
they inadequate? ActaCytol
1986; 30:258.7. ACOG. Cervical cytology: evaluation and management of abnormalities.
ACOG
Technicall Bulletin Number 183, August 1993. Int J Gynecol Obstet 1993; 43:.212-20' 8. Sato S, Makino H, Matsunaga G, Yajima A. False negativerate in mass screening for cervical cancer' Acta Cytol 1998; 42:836-'1.
9. Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol 1985; 29:1043-6' 10. Rubio CA. False negative in cervical cytology: Can they be
avoided? Acta Cytol 1981 ; 25:199 -202.
11. Taylor PT Jr, Andersen WA, Barber SR' Covell JL, Smith EB, Underwood PB Jr. The screening Papanicolaou smear:
contribution
of
the endocervlcal brush. Obstet Gynecol 1987 70:'134-8.12. Orr JWJr, Barrett JM, Orr PF, Holloway RW, Holimon JL' The efficacy and safety of the cytobrush during pregnancy' Gynecol Oncol 1992; 44.260-2.
13. Bar-Am
A, Niv
J, Segal A. Taking a satisfactory cervical cytologic smear. Isit
really an easy procedure? Acta Cytol1997; 41:l'781-4.
14. Patterson MEL, Peel KR, Joslin CAF. Cervical smear
his-tories
of
500 womenwith
invasive cervical cancer in Yorkshire. Br Med J 1984; 289:896-8.